Robillard J E, Page W V, Mathews M S, Schutte B C, Nuyt A M, Segar J L
Department of Pediatrics, University of Iowa, Iowa City 52242, USA.
Pediatr Res. 1995 Dec;38(6):896-904. doi: 10.1203/00006450-199512000-00012.
Previous studies have shown that angiotensin II subtype 2 (AT2) receptors appear early during renal embryonic development. Factors involved in the regulation of AT2 receptors during renal development, however, have not been investigated. The present study was designed 1) to characterize the ontogeny of renal AT2 gene expression during the last half of gestation in fetal sheep and newborn lambs, 2) to compare changes in AT1 and AT2 gene expression during renal development, 3) to determine the influence of AII in modulating renal AT1 and AT2 gene expression during fetal life, and 4) to characterize the role of cortisol in modulating renal AT2 gene expression during the last trimester of gestation in fetal sheep. To perform these studies, we first isolated and cloned a polymerase chain reaction product that has 92 and 90% homology with the cDNA encoding the human and rat AT2 receptors, respectively. Using this sheep AT2 cDNA probe, we demonstrated that the sheep AT2 gene was encoded in a single locus. In addition, we showed that renal AT2 mRNA expression was high early during fetal life (60-90-d gestation) and decreased rapidly thereafter. In contrast, the expression of renal AT1 receptor gene was low at 60-d gestation and increased during the last trimester of gestation. We found that a continuous i.v. infusion (1 mL/h) of AII (9.5 mM/n) for 24 h, which raised plasma AII levels from 84 +/- 9 pg/mL to 210 +/- 21 pg/mL, decreased the expression of both renal AT1 and AT2 genes in third trimester fetal sheep. On the other hand, we observed that cortisol, known to decrease AT1 gene expression in the fetus, had no effect on AT2 gene expression. In summary, this study demonstrates that AII, but not glucocorticoids, contributes to the regulation of renal AT2 gene expression during development and that there is differential regulation of AT1 and AT2 receptors.
先前的研究表明,血管紧张素II 2型(AT2)受体在肾脏胚胎发育早期就已出现。然而,尚未对肾脏发育过程中参与AT2受体调节的因素进行研究。本研究旨在:1)描述胎羊和新生羔羊妊娠后半期肾脏AT2基因表达的个体发生情况;2)比较肾脏发育过程中AT1和AT2基因表达的变化;3)确定血管紧张素II(AII)在胎儿期调节肾脏AT1和AT2基因表达中的作用;4)描述皮质醇在胎羊妊娠晚期调节肾脏AT2基因表达中的作用。为进行这些研究,我们首先分离并克隆了一种聚合酶链反应产物,该产物与编码人类和大鼠AT2受体的cDNA分别具有92%和90%的同源性。使用这种绵羊AT2 cDNA探针,我们证明绵羊AT2基因由单个基因座编码。此外,我们发现肾脏AT2 mRNA表达在胎儿期早期(妊娠60 - 90天)较高,此后迅速下降。相反,肾脏AT1受体基因的表达在妊娠60天时较低,并在妊娠晚期增加。我们发现,连续静脉输注(1 mL/h)AII(9.5 mM/n)24小时,可使血浆AII水平从84±9 pg/mL升高至210±21 pg/mL,降低妊娠晚期胎羊肾脏AT1和AT2基因的表达。另一方面,我们观察到,已知可降低胎儿AT1基因表达的皮质醇对AT2基因表达没有影响。总之,本研究表明,在发育过程中,AII而非糖皮质激素参与了肾脏AT2基因表达的调节,并且AT1和AT2受体存在差异调节。